Rallybio Corp Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rallybio Corp quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Rallybio Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.1M, a 37.7% increase year-over-year.
  • Rallybio Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$70M, a 6.56% increase year-over-year.
  • Rallybio Corp annual Operating Income (Loss) for 2023 was -$78.9M, a 16.3% decline from 2022.
  • Rallybio Corp annual Operating Income (Loss) for 2022 was -$67.9M, a 48.7% decline from 2021.
  • Rallybio Corp annual Operating Income (Loss) for 2021 was -$45.6M, a 80.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$78.9M -$11M -16.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 -$67.9M -$22.2M -48.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 -$45.6M -$20.3M -80.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 -$25.3M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.